Defining the mutational profile of lower-risk myelodysplastic neoplasm patients with respect to disease progression using next-generation sequencing and pyrosequencing.

Autor: Adamska M; Department of Haematology and Bone Marrow Transplantation, Poznań University of Medical Sciences, Poznań, Poland.; Doctoral School, Poznań University of Medical Sciences, Poznań, Poland., Kowal-Wiśniewska E; Department of Haematology and Bone Marrow Transplantation, Poznań University of Medical Sciences, Poznań, Poland.; Institute of Human Genetics, Polish Academy of Sciences, Poznań, Poland., Czerwińska-Rybak J; Department of Haematology and Bone Marrow Transplantation, Poznań University of Medical Sciences, Poznań, Poland., Kiwerska K; Institute of Human Genetics, Polish Academy of Sciences, Poznań, Poland., Barańska M; Doctoral School, Poznań University of Medical Sciences, Poznań, Poland., Gronowska W; Student Scientific Society, Poznań University of Medical Sciences, Poznań, Poland., Loba J; Student Scientific Society, Poznań University of Medical Sciences, Poznań, Poland., Brzeźniakiewicz-Janus K; Department of Haematology, Oncology, and Radiotherapy, University of Zielona Góra, Multi-specialist Hospital Gorzów Wielkopolski, Poland., Wasilewska E; Department of Haematology, Medical University of Białystok, Białystok, Poland., Łanocha A; Department of Haematology with Bone Marrow Transplantation Unit, University Hospital No. 1 of Pomeranian Medical University, Szczecin, Poland., Jarmuż-Szymczak M; Department of Haematology and Bone Marrow Transplantation, Poznań University of Medical Sciences, Poznań, Poland.; Institute of Human Genetics, Polish Academy of Sciences, Poznań, Poland., Gil L; Department of Haematology and Bone Marrow Transplantation, Poznań University of Medical Sciences, Poznań, Poland.

Publikováno v: Contemporary oncology (Poznan, Poland) [Contemp Oncol (Pozn)] 2023; Vol. 27 (4), pp. 269-279. Date of Electronic Publication: 2024 Feb 17.